Boveda, S;
Garcia, R;
Defaye, P;
Piot, O;
Narayanan, K;
Barra, S;
Gras, D;
... DAI-PP investigators, .; + view all
(2019)
Implantable cardioverter defibrillator therapy for primary prevention of sudden cardiac death in the real world: Main findings from the French multicentre DAI-PP programme (pilot phase).
Archives of Cardiovascular Diseases
, 112
(8-9)
pp. 523-531.
10.1016/j.acvd.2019.05.005.
Preview |
Text
Bebiano Da Providencia E Costa_Implantable cardioverter defibrillator therapy for primary prevention of sudden cardiac death in the real world_AAM.pdf - Accepted Version Download (402kB) | Preview |
Abstract
This review summarizes the main findings of the French multicentre DAI-PP pilot programme, and discusses the related clinical and research perspectives. This project included retrospectively (2002–2012 period) more than 5000 subjects with structural heart disease who received an implantable cardioverter defibrillator (ICD) for primary prevention of sudden cardiac death, and were followed for a mean period of 3 years. The pilot phase of the DAI-PP programme has provided valuable information on several practical and clinically relevant aspects of primary prevention ICD implantation in the real-world population, which are summarized in this review. This pilot has led to a prospective evaluation that started in May 2018, assessing ICD therapy in primary and secondary prevention in patients with structural and electrical heart diseases, with remote monitoring follow-up using a dedicated platform. This should further enhance our understanding of sudden cardiac death, to eventually optimize the field of preventative actions.
| Type: | Article |
|---|---|
| Title: | Implantable cardioverter defibrillator therapy for primary prevention of sudden cardiac death in the real world: Main findings from the French multicentre DAI-PP programme (pilot phase) |
| Location: | Netherlands |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1016/j.acvd.2019.05.005 |
| Publisher version: | https://doi.org/10.1016/j.acvd.2019.05.005 |
| Language: | English |
| Additional information: | This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions. |
| Keywords: | Complications, Défibrillateur automatique implantable, Epidemiology |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute of Health Informatics |
| URI: | https://discovery.ucl.ac.uk/id/eprint/10082636 |
Archive Staff Only
 |
View Item |
